Innophore GmbH
PrivateTotal Funding Raised
$2,100
Company Overview
Innophore GmbH is a biotechnology company that provides an AI-driven enzyme discovery and drug-safety screening platform for the pharmaceutical, chemical, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innophore GmbH Comparables
Compare Innophore GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imperagen | 88% | |
| Zymvol Biomodeling | 86% | |
| Biomatter | 83% | |
Innophore GmbH Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Innophore GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Steirische Wirtschaftsförderungsgesellschaft | Grant, Accelerator |
| EOSS Industries | Accelerator |
| Science Park Graz | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 596% MoM.
- Apr 1, 2026
Monthly visitors grew 231% MoM.
Innophore GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innophore GmbH's valuation, stock price, and market status.